Company Filing History:
1 out of 295 
2 out of 832,812 Years Active: 2017-2018
Title: The Innovative Contributions of George Zogopoulos
Introduction
George Zogopoulos is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on TC-PTP inhibitors. With a total of 3 patents, Zogopoulos has established himself as a key figure in the development of novel therapeutic compounds.
Latest Patents
Zogopoulos's latest patents focus on TC-PTP inhibitors as activators for antigen-presenting cells (APCs) in immunotherapy. The invention encompasses a novel class of compounds that inhibit the TC-PTP enzyme. These compounds are designed to be included in pharmaceutical compositions aimed at treating or preventing TC-PTP mediated diseases, including cancer. The methods developed utilize these inhibitors to activate dendritic cells, enhancing their role in the immunotherapeutic treatment of various diseases.
Career Highlights
Throughout his career, Zogopoulos has worked with prestigious institutions, including the Royal Institution for the Advancement of Learning/McGill University. His research has contributed to advancements in the understanding and treatment of diseases through innovative therapeutic approaches.
Collaborations
Zogopoulos has collaborated with notable colleagues, including Michel L. Tremblay and Claudia Penafuerte. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of immunotherapy.
Conclusion
George Zogopoulos's work exemplifies the spirit of innovation in the realm of medical research. His contributions to immunotherapy through the development of TC-PTP inhibitors highlight the importance of continued research and collaboration in advancing healthcare solutions.